By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Biomarker development and software firm NeoProteomics announced late on Friday that it has reached an exclusive option agreement to license technologies from Case Western Reserve University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.